HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer. Posted bybrigittemeiswinkel 7. December 2020 Rinnerthaler, G; Gampenrieder, SP; Greil, R. Int J Mol Sci. 2019 Mar 5;20(5):1115. doi: 10.3390/ijms20051115. https://pubmed.ncbi.nlm.nih.gov/30841523/